Literature DB >> 1846183

Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains.

B Jubelt1, S L Ropka, S Goldfarb, C Waltenbaugh, R P Oates.   

Abstract

Susceptibility to human poliovirus-induced disease in different inbred mouse strains was analyzed after intracerebral inoculation of two mouse-adapted type 2 polioviruses, the attenuated W-2 strain and the virulent Lansing strain. In contrast to inoculation with the Lansing strain, which was invariably lethal, inoculation with the W-2 strain defined three groups of mice with high, intermediate, or low disease incidence. Those in the high-disease-incidence group, the DBA/1J and DBA/2J mice, exhibited a high level of virus replication in the spinal cord by day 2 postinfection, with no detectable neutralizing-antibody response. Mice in the intermediate- and low-incidence groups had lower levels of virus replication in the spinal cord and/or produced neutralizing antibodies. No correlation was observed between H-2 haplotype and the extent of virus replication, production of neutralizing or enzyme-linked immunosorbent assay-detectable antibodies, or T-cell-proliferative response. However, mice of the H-2k haplotype manifested a low incidence of disease.

Entities:  

Mesh:

Year:  1991        PMID: 1846183      PMCID: PMC239854     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responses.

Authors:  K G Wang; L Z Sun; B Jubelt; C Waltenbaugh
Journal:  Cell Immunol       Date:  1989-04-01       Impact factor: 4.868

2.  Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.

Authors:  R A Weiss; P R Clapham; R Cheingsong-Popov; A G Dalgleish; C A Carne; I V Weller; R S Tedder
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

3.  Cell-mediated immune responses to poliovirus II. Survey of delayed hypersensitivity and T-cell proliferative responses in inbred mouse strains.

Authors:  K Wang; L Sun; B Jubelt; C Waltenbaugh
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

4.  Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis: I. Clinical, pathologic, and immunologic studies.

Authors:  B Jubelt; J B Meagher
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

5.  Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis: II. Virologic studies.

Authors:  B Jubelt; J B Meagher
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

6.  Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Authors:  C J Gauntt; P T Gomez; P S Duffey; J A Grant; D W Trent; S M Witherspoon; R E Paque
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Study of the HLA antigen in Arab children with paralytic poliomyelitis.

Authors:  E E Lasch; H Joshua; E Gazit; M El-Massri; O Marcus; R Zamir
Journal:  Isr J Med Sci       Date:  1979-01

8.  Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

Authors:  R J Clatch; R W Melvold; S D Miller; H L Lipton
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis.

Authors:  O Narayan; D Sheffer; D E Griffin; J Clements; J Hess
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

10.  Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; Y O Stone; M H Hatch
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

View more
  6 in total

1.  Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.

Authors:  M J Bouchard; D H Lam; V R Racaniello
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

2.  Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.

Authors:  Shaukat Khan; Hidemi Toyoda; Melissa Linehan; Akiko Iwasaki; Akio Nomoto; Günter Bernhardt; Jeronimo Cello; Eckard Wimmer
Journal:  J Gen Virol       Date:  2014-04-30       Impact factor: 3.891

3.  Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus.

Authors:  D C Thach; T Kimura; D E Griffin
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Authors:  M Tardy-Panit; B Blondel; A Martin; F Tekaia; F Horaud; F Delpeyroux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.

Authors:  S Koike; C Taya; J Aoki; Y Matsuda; I Ise; H Takeda; T Matsuzaki; H Amanuma; H Yonekawa; A Nomoto
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo.

Authors:  Matthijs Raaben; Henk-Jan Prins; Anton C Martens; Peter J M Rottier; Cornelis A M De Haan
Journal:  Cell Microbiol       Date:  2009-02-10       Impact factor: 3.715

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.